Skip to Content

NeuroOne Medical Technologies Corp NMTC

Morningstar Rating
$1.20 0.01 (0.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NMTC is trading at a 45% discount.
Price
$1.27
Fair Value
$1.22
Uncertainty
Extreme
1-Star Price
$28.75
5-Star Price
$6.45
Economic Moat
Fkrv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NMTC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.21
Day Range
$1.181.23
52-Week Range
$0.852.06
Bid/Ask
$1.18 / $1.21
Market Cap
$31.12 Mil
Volume/Avg
151,171 / 223,039

Key Statistics

Price/Earnings (Normalized)
Price/Sales
8.59
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
16

Valuation

Metric
NMTC
Price/Earnings (Normalized)
Price/Book Value
6.77
Price/Sales
8.59
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NMTC
Quick Ratio
2.33
Current Ratio
3.68
Interest Coverage
Quick Ratio
NMTC

Profitability

Metric
NMTC
Return on Assets (Normalized)
−169.08%
Return on Equity (Normalized)
−218.38%
Return on Invested Capital (Normalized)
−210.43%
Return on Assets
NMTC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesFgjcwvsBzyszs$196.9 Bil
SYK
Stryker CorpBvmmbbtqsLsfj$136.5 Bil
MDT
Medtronic PLCWltgcrrDfyfh$115.4 Bil
BSX
Boston Scientific CorpSdmvylflMkcxxm$100.9 Bil
EW
Edwards Lifesciences CorpYvyjypjmSlmxxw$57.3 Bil
DXCM
DexCom IncRglhhyyprqPkjwd$53.8 Bil
ZBH
Zimmer Biomet Holdings IncCjgqsxbcRrq$27.2 Bil
ALGN
Align Technology IncDfrvwybdDlspv$24.6 Bil
PHG
Koninklijke Philips NV ADRQpqczfqrxFysmqjc$18.4 Bil
PODD
Insulet CorpWmznlmwkTgpzty$11.8 Bil

Sponsor Center